Description
A metabolite of α-tocotrienol that has antioxidant and ferroptosis inhibitory activity; inhibits BSO-induced decreases in cell in primary fibroblasts isolated from patients with Friedreich’s ataxia or Leigh syndrome (EC50s = 24 and 30 nM, respectively); inhibits RSL3-induced cell death and lipid peroxidation in primary fibroblasts isolated from patients with PCH6 (EC50s = 17.3-21.8 and 33.1-57.6 nM, respectively)
Formal name: 2-[(3R,6E,10E)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl]-3,5,6-trimethyl-2,5-cyclohexadiene-1,4-dione
Synonyms: EPI 743|α-Tocotrienol quinone
Molecular weight: 440.7
CAS: 1213269-98-7
Purity: ≥98%
Formulation: A solution in ethanol
Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cell Biology|Cell Death|Ferroptosis||Research Area|Cell Biology|Mitochondrial Biology||Research Area|Neuroscience|Seizure Disorders||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Lipid Peroxidation||Research Area|Oxidative Stress & Reactive Species|Reactive Sulfur|Glutathione||Research Area|Toxicology|Drug Metabolism|Drug Metabolites